As part of a $4.5 million, nine-year effort to employ molecular imaging and nanotechnology in developing “theragnosis”—simultaneous diagnostics and therapeutics—partnering research teams from Purdue University’s Discovery Park and the Korean Institute of Science and Technology will hold a daylong symposium, Sept. 6, in West Lafayette, Ind.